Medasense is transforming the way PAIN is being assessed and treated worldwide. Through our breakthrough NOL® AI technology and sensing platform, we quantify pain response to optimize care and avoid overmedication.
Medasense’s flagship product, PMD-200™, is used in critical care settings, where patients are unable to communicate, to visualize pain response and personalize treatment. Clinical studies have demonstrated its impact on patient safety and outcomes – including opioid sparing and lower pain scores reported by patients.
PMD-200™ is distributed in Europe by Medtronic, and is also commercially available in Canada, Latin America, Israel, Australia and the United Arab Emirates. It enables connectivity with Philips and Mindray patient monitors.
Along our path to improve pain care in additional settings, we are harnessing our AI capabilities with NOLedge™, an agile investigational device to lead prediction, stratification and prevention strategies that will enable better pain management and reduce healthcare expenditures.
Medasense’s flagship product, PMD-200™, is used in critical care settings, where patients are unable to communicate, to visualize pain response and personalize treatment. Clinical studies have demonstrated its impact on patient safety and outcomes – including opioid sparing and lower pain scores reported by patients.
PMD-200™ is distributed in Europe by Medtronic, and is also commercially available in Canada, Latin America, Israel, Australia and the United Arab Emirates. It enables connectivity with Philips and Mindray patient monitors.
Along our path to improve pain care in additional settings, we are harnessing our AI capabilities with NOLedge™, an agile investigational device to lead prediction, stratification and prevention strategies that will enable better pain management and reduce healthcare expenditures.
Location: Israel, Tel Aviv District, Ramat Gan
Employees: 11-50
Phone: +972 73-769-0321
Total raised: $26M
Founded date: 2008
Investors 3
| Date | Name | Website |
| - | Olive Tree... | olivetree.... |
| - | Asabys Par... | asabys.com... |
| - | OTV | otv.vc |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 22.09.2020 | Series C | $18M | - |
| 04.03.2016 | Series B | $8M | - |
Mentions in press and media 15
| Date | Title | Description |
| 04.08.2026 | Medasense Biometrics Receives Innovative Technology Contract from Vizient® for PMD-200™ with NOL Technology | With NOL monitoring technology, clinicians can personalize analgesic dosing based on a patient’s actual physiological requirements Medasense's PMD-200™ pain response (nociception) monitoring system with NOL technology has received an Innova... |
| 07.07.2026 | Pain Monitoring Data to be Available in Hospital EHRs through Philips Capsule | Pain monitoring data obtained via Medasense’s PMD-200™ patient monitor and its NOL-Nociception Level Index® to be available in hospital EHRs through Philips Capsule The integration enables streaming of the patient’s NOL-Nociception Level In... |
| 31.03.2026 | Medasense and Jefferson Health to Collaborate on Study of Pain Monitoring Technology in Spine Surgery | Medasense Biometrics NOL technology can help improve perioperative outcomes Collaboration aims to establish real-world clinical and economic evidence for NOL-guided anesthesia. Partnering with a prestigious institution like Jefferson Health... |
| 25.02.2026 | Medasense Appoints MedTech Leader Peter Wehrly as Executive Chairman of the Board | Peter Werhly Former Medtronic and Covidien Executive to Accelerate Commercial Scale-Up and Global Expansion I am excited to join Medasense at a stage where focused commercial execution and strategic alliances can significantly accelerate im... |
| 12.09.2024 | Medasense Selected to Exhibit the NOL – Nociception Level Index Technology at Vizient Innovative Technology Exchange | Medasense will showcase its AI-powered NOL technology at Vizient's Innovative Technology Exchange, revolutionizing pain monitoring for improved patient care. BETHLEHEM, PA, UNITED STATES, September 12, 2024 /EINPresswire.com/ -- Medasense B... |
| 04.06.2024 | Panakeia, LLC Partners with Medasense to Distribute 1st FDA authorized Nociception Monitor in US Government Institutions | Medasense has reached a strategic agreement with Panakeia to distribute Medasense's PMD-200 device to United States government institutions. RAMAT GAN, ISRAEL, June 4, 2024 /EINPresswire.com/ -- Medasense, a pioneer in pain monitoring techn... |
| 27.04.2021 | Pain Monitoring Technology (NOL) is Shown to Reduce Postoperative Pain and Health Costs USA - English USA - English USA - English USA - English USA - English | |
| 21.03.2021 | Israeli pain monitoring co Medasense raises $18m | The company's technology uses a multi-parametric sensor platform and advanced AI algorithms to convert complicated data into a patient's "Signature of Pain." |
| 28.10.2020 | NOL Pain Response Monitoring Secures Marketing Approval in Brazil USA - English USA - English Brazil - Português USA - English | |
| 29.09.2020 | New Study: Postoperative Pain Can Be Reduced by Using NOL Monitoring to Guide Analgesic Medication During Surgery USA - English USA - English USA - English |
Show more